Literature DB >> 9492723

Clinical-pathological study of uterine leiomyomas with high mitotic activity.

R Dgani1, B Piura, G Ben-Baruch, M Open, M Glezerman, D Nass, B Czernobilsky, I Yanai-Inbar, U Elchalal.   

Abstract

OBJECTIVE: To evaluate clinical-pathological aspects of mitotically active leiomyomas. STUDY
DESIGN: Twenty patients with smooth muscle tumors of the uterus, with 5-9 mitotic figures per 10 high power fields and without atypia or necrosis were studied. The clinical and pathological characteristics of these tumors were reviewed and analyzed.
RESULTS: Patients' ages ranged from 33 to 63 years (mean 42.5 years). The size of the tumors ranged from 1.5 to 9.5 cm (mean 5.4 cm). On gross examination all tumors appeared as typical leiomyomas. Treatment included hysterectomy in 16 patients and myomectomy in four. Follow-up periods ranged from 1.5 to 11 years (mean 6.8 years). None of the patients developed a recurrent tumor.
CONCLUSION: The benign clinical behavior of such tumors supports their current designation as mitotically active leiomyomas, thus deleting the previous misnomer 'smooth muscle tumors of uncertain malignant potential'. Myomectomy is an appropriate treatment, particularly in young patients interested in reproduction.

Entities:  

Mesh:

Year:  1998        PMID: 9492723     DOI: 10.1034/j.1600-0412.1998.770116.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  4 in total

1.  Gonadotropin-releasing hormone agonist increases expression of osmotic response genes in leiomyoma cells.

Authors:  Desireé M McCarthy-Keith; Minnie Malik; Joy Britten; James Segars; William H Catherino
Journal:  Fertil Steril       Date:  2011-04-15       Impact factor: 7.329

2.  Acute abdomen with a parasitic smooth muscle tumor of uncertain malignant potential (STUMP) in pregnancy; a unique case report.

Authors:  Hannah Louise Price; Tanne Daniels; Tava Mudzamiri; Archana Pandita; Victoria Carlsen
Journal:  Int J Surg Case Rep       Date:  2022-10-13

3.  Uterine smooth muscle tumor of uncertain malignant potential: fertility and clinical outcomes.

Authors:  Hanifi Şahin; Funda Karatas; Gonca Coban; Özlem Özen; Özlem Erdem; Mehmet Anıl Onan; Ali Ayhan
Journal:  J Gynecol Oncol       Date:  2019-02-04       Impact factor: 4.401

4.  Successful pregnancy following myomectomy for uterine smooth muscle tumor of uncertain malignant potential: A case report and review of the literature.

Authors:  Jessica E Campbell; Jennifer F Knudtson; Philip T Valente; Randal D Robinson; Edward R Kost
Journal:  Gynecol Oncol Rep       Date:  2015-08-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.